Pedro Rodriguez Cutillas
Gründer bei Kinomica Ltd.
Aktive Positionen von Pedro Rodriguez Cutillas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Kinomica Ltd.
Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Direktor/Vorstandsmitglied | 01.10.2016 | - |
Gründer | 01.10.2016 | - |
Karriereverlauf von Pedro Rodriguez Cutillas
Ehemalige bekannte Positionen von Pedro Rodriguez Cutillas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Pronostics Ltd.
Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | - | - |
Barts Cancer Institute
Barts Cancer Institute Miscellaneous Commercial ServicesCommercial Services Part of St Bartholomew's Hospital Medical College, Barts Cancer Institute operates as a cancer research center. The company is based in London, UK. | Corporate Officer/Principal | - | - |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - | - |
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 15.03.2011 | - |
Gründer | 15.03.2011 | - |
Ausbildung von Pedro Rodriguez Cutillas
University College London | Doctorate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Operativ
Director/Board Member | 3 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Activiomics Ltd.
Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Activiomics Ltd. develops innovative technologies that utilize mass spectrometry to interrogate and interpret the activity of cellular signaling pathways. It offers phosphoproteomics for biomaker discovery and drug profiling. The company was founded by Bart Vanhaesebroeck and Pedro Rodriguez Cutillas in 2009 and is headquartered in London, the United Kingdom. | Commercial Services |
Barts Cancer Institute
Barts Cancer Institute Miscellaneous Commercial ServicesCommercial Services Part of St Bartholomew's Hospital Medical College, Barts Cancer Institute operates as a cancer research center. The company is based in London, UK. | Commercial Services |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
Pronostics Ltd.
Pronostics Ltd. Pharmaceuticals: MajorHealth Technology Pronostics Ltd. operates as a clinical diagnostics company. It offers diagnostic and disease monitoring applications. The company’s products include UltraPlex line of automated multiplexing solutions, such as UltraPlex multiplexed assays to multiplex a range of assays for applications in direct immunoassay; and UltraPlex ANA, a barcoded immunoassay for testing of autoimmune disease biomarkers that allows hospitals and laboratories to perform automated profiles of patient. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Kinomica Ltd.
Kinomica Ltd. BiotechnologyHealth Technology Kinomica Ltd. develops anti-cancer drug therapies. The company is based in Macclesfield, UK. The British company was founded in 2016 by David Britton, Pedro Rodriguez Cutillas. The CEO is Jane Theaker. | Health Technology |